You are here

  • Home
  • Archive
  • Volume 67, Issue 4
  • Bronchoalveolar lavage-directed therapy does not affect prevalence of Pseudomonas aeruginosa infection and structural lung injury in children with cystic fibrosis

Article Text

Article menu

Download PDFPDF

Miscellaneous
Journal club
Bronchoalveolar lavage-directed therapy does not affect prevalence of Pseudomonas aeruginosa infection and structural lung injury in children with cystic fibrosis
Free
  1. H Haja Mydin
  1. Correspondence to Dr Helmy Haja Mydin, Department of Respiratory Medicine, Aberdeen Royal Infirmary, Foresterhill, Aberdeen AB25 2ZN, UK; enidan{at}doctors.org.uk

https://doi.org/10.1136/thoraxjnl-2011-201039

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Early Pseudomonas aeruginosa pulmonary infections lead to increased morbidity and mortality in children with cystic fibrosis (CF). As this diagnosis is difficult to ascertain in the non-expectorating patient, the authors set out to determine if bronchoalveolar lavage (BAL)-directed therapy during the first 5 years of life leads to better outcomes than standard practice (which is therapy based …

    View Full Text